Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | TP53 | P04637 | 1/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.61 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | HTT | P42858 | 2/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
| ▸ | NPC1 | O15118 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | RAB9A | P51151 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | BCHE | P06276 | 10/20 | 0.44 |
| ▸ | ACHE | P22303 | 10/20 | 0.44 |
| ▸ | CHKA | P35790 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2609284 | 1.00 | MEN1 (0.61) | MEN1TP53CYP1A2CYP2D6MAPT | |
| Bromide SCHEMBL7170664 | 0.98 | MEN1 (0.59) | MEN1TP53CYP1A2CYP2D6MAPT | |
| SCHEMBL5711022 | 0.92 | MEN1 (0.53) | MEN1TP53CYP1A2CYP2D6MAPT | |
| SCHEMBL2609281 | 0.90 | MEN1 (0.62) | MEN1TP53CYP1A2CYP2D6MAPT | |
| SCHEMBL5711020 | 0.88 | MEN1 (0.50) | MEN1TP53CYP1A2CYP2D6MAPT | |
| SCHEMBL5710989 | 0.88 | MAPT (0.50) | MEN1TP53CYP1A2CYP2D6MAPT | |
| SCHEMBL5710972 | 0.84 | ALDH1A1 (0.54) | MEN1TP53CYP1A2CYP2D6MAPT | |
| SCHEMBL7170348 | 0.84 | MEN1 (0.46) | MEN1TP53CYP1A2CYP2D6MAPT | |
| Bromide SCHEMBL7169216 | 0.82 | ALDH1A1 (0.53) | MEN1TP53CYP1A2CYP2D6MAPT | |
| SCHEMBL21490437 | 0.80 | CHRNA7 (0.46) | MEN1TP53CYP1A2CYP2D6MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10464900-B2 | Electrochromic compounds with improved color stability in their radical states | GENTEX CORPORATION (US) | 2019-11-05 | — | — | US | disclosed |
| US-20180346421-A1 | ELECTROCHROMIC COMPOUNDS WITH IMPROVED COLOR STABILITY IN THEIR RADICAL STATES | GENTEX CORPORATION | 2018-12-06 | — | — | US | disclosed |
| US-10040763-B2 | Electrochromic compounds with improved color stability in their radical states | GENTEX CORPORATION (US) | 2018-08-07 | — | — | US | disclosed |
| US-10040763-B2 | Electrochromic compounds with improved color stability in their radical states | GENTEX CORPORATION (US) | 2018-08-07 | — | — | US | disclosed |
| US-20160229803-A1 | ELECTROCHROMIC COMPOUNDS WITH IMPROVED COLOR STABILITY IN THEIR RADICAL STATES | GENTEX CORPORATION | 2016-08-11 | — | — | US | disclosed |
| US-20160229803-A1 | ELECTROCHROMIC COMPOUNDS WITH IMPROVED COLOR STABILITY IN THEIR RADICAL STATES | GENTEX CORPORATION | 2016-08-11 | — | — | US | disclosed |
| US-8294975-B2 | Automotive rearview mirror assembly | DONNELLY CORPORATION (US) | 2012-10-23 | — | — | US | disclosed |
| US-8164817-B2 | Method of forming a mirrored bent cut glass shape for vehicular exterior rearview mirror assembly | DONNELLY CORPORATION (US) | 2012-04-24 | — | — | US | disclosed |
| US-20110045172-A1 | METHOD OF FORMING A MIRRORED BENT CUT GLASS SHAPE FOR VEHICULAR EXTERIOR REARVIEW MIRROR ASSEMBLY | DONNELLY CORPORATION (US) | 2011-02-24 | — | — | US | disclosed |
| US-7202987-B2 | Electrochromic polymeric solid films, manufacturing electrochromic devices using such solid films, and processes for making such solid films and devices | DONNELLY CORPORATION (US) | 2007-04-10 | — | — | US | disclosed |
| EP-1027397-B1 | ELECTROCHROME POLYMER SYSTEMS | BAYER INNOVATION GMBH (DE) | 2006-10-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10464900-B2 | Electrochromic compounds with improved color stability in their radical states | ETV6, PMS2, EED | MEN1 2956/4885TP53 308/4885CYP1A2 650/4885 |
| US-10040763-B2 | Electrochromic compounds with improved color stability in their radical states | ETV6, CYCS, SCO2 | MEN1 3053/4885TP53 676/4885CYP1A2 515/4885 |
| US-20160229803-A1 | ELECTROCHROMIC COMPOUNDS WITH IMPROVED COLOR STABILITY IN THEIR RADICAL STATES | ETV6, CYCS, SCO2 | MEN1 3053/4885TP53 676/4885CYP1A2 515/4885 |
| US-20180346421-A1 | ELECTROCHROMIC COMPOUNDS WITH IMPROVED COLOR STABILITY IN THEIR RADICAL STATES | ETV6, PMS2, EED | MEN1 2956/4885TP53 308/4885CYP1A2 650/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.